Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-23

Clinical Trial Update: Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial [Phase 2]

View source ↗

Summary

A Phase 2 randomized controlled trial is evaluating whether acetylcysteine can protect against cisplatin-induced ototoxicity in patients undergoing cisplatin th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acetylcysteine (Acetylcysteine)

Snippet

Sponsor: Siriraj Hospital | Conditions: Cisplatin-induced Ototoxicity, Sensorineural Hearing Loss | Phase 2 | Status: RECRUITING